Inventaire - your friends and communities are your best library - Inventaire

Beyond CA125: the coming of age of ovarian cancer biomarkers

author

George Coukos

published in: Biomarkers in Medicine

date of publication: 2009-06-01

language: English

main subject: drug discovery, biomarker, ovarian cancer

Cites articles 141

Date

Title

Authors

2009-02-04

SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device
2009-03-11

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Aleksandra Gentry-Maharaj, Lesley Fallowfield, Usha Menon, Alistair McGuire, Matthew Burnell, Naveena Singh, Mourad W Seif, Keith Godfrey, Jonathan Herod, Karin Williamson, Robert Woolas, Leeson Simon, Derek Cruickshank, Mahesh K B Parmar, Nazar Amso, Rachel Hallett, Susan Philpott
2009-02-01

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

Geertruida H de Bock
2008-02

Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10

Toyomasa Katagiri
2008

Cancer statistics, 2008

Michael Thun
2008-11-01

Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer

Ajay Pratap Singh, Shantibhusan Senapati
2008-10-26

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
2008-10-14

New insights into the pathogenesis of serous ovarian cancer and its clinical impact
2008-09-28

Modulation of the antitumor immune response by complement

Fabian Benencia, George Coukos, John D. Lambris, Maciej M Markiewski
2008-08-07

Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers

Eleftherios P. Diamandis
2008-07-24

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery
2008-08-01

Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation
2008-05-12

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

Robin Farias-Eisner
2008-04-01

Mining the plasma proteome for cancer biomarkers

Sharon J Pitteri
2008-03-14

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

Shelley S. Tworoger, Judy E. Garber
2008-01-01

Serous carcinogenesis in the fallopian tube: a descriptive classification.

Ronny Drapkin
2008-06-27

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.

Laura J. Havrilesky, Andrew Berchuck
2008-10-23

Ovarian cancer early detection claims are biased.

George Coukos, Brad H Nelson
2008-01-02

Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer

Albert C. Koong, Odd Terje Brustugun, Robert Tibshirani
2008-10-23

The importance of test positive predictive value in ovarian cancer screening
2008-02-07

Diagnostic markers for early detection of ovarian cancer
2007-12-20

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Daniel Irimia, Mehmet Toner, Daniel Haber, Lecia V Sequist, Shyamala Maheswaran, Eunice L Kwak
2007-09-15

High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma
2007-02-15

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

David M. Gershenson, Anil Sood
2007-12-01

CA125 in ovarian cancer
2007-12-05

Effects of blood collection conditions on ovarian cancer serum markers

Garnet L Anderson, Brad H Nelson
2007-01-01

Markers of angiogenesis in ovarian cancer

Anil Sood
2007-11-30

Design of recombinant antibody microarrays for cell surface membrane proteomics
2007-10-22

Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays

Michael P. Snyder
2007-11-01

Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications
2007-09-01

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

Judy E. Garber, Colleen Feltmate
2007-08-01

Is proteomics the new genomics?

Jürgen Cox, Matthias Mann

Article - wd:Q24651567

Welcome to Inventaire

the library of your friends and communities

you are offline